drugset / Trial / NCT03403569
Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The traditional Chinese herbal medicine Triptolide Wilfordii has displayed remarkable effect on the treatment of autoimmune diseases such as rheumatoid arthritis. Now that immunosuppression therapy has recently become a new strategy for HIV infection, it's reasonable to expect the anti-inflammatory effect of Triptolide Wilfordii in HIV infected patients. So we designed a randomized, double-blinded, placebo-controlled study to explore the efficacy and safety of Triptolide Wilfordii in new-onset HIV infection.
Timeline
- Start
- 2018-09-01
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptolide Wilfordii | Traditional medicine (herbal / TCM) | 20 mg | Oral |